MINERVAX ApS: Financial statements 2015
CVR: 32673287
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
MINERVAX ApS (CVR 32673287) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK -15,625,668 and a net result of DKK -13,102,889 compared with DKK -4,412,692 the year before. Equity in the 2015 report amounted to DKK 412,617. The solvency ratio was 5.2%.
- Gross Profit
- DKK -15,625,668
- Profit/Loss
- DKK -13,102,889
- Equity
- DKK 412,617
- Total Assets
- DKK 7,869,838
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | -15.6 mio. | -13.1 mio. | 413 t. | - |
| 2014 | - | -5.4 mio. | -4.4 mio. | 13.5 mio. | - |
| 2013 | 4.6 mio. | -2.6 mio. | -2.1 mio. | -719 t. | - |
| 2012 | - | -1.1 mio. | -846 t. | 1.4 mio. | - |
Official annual report
How creditworthy is MINERVAX ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
MINERVAX ApS has published its annual report for 2014. Gross profit came to DKK -5,356,678, and the net result was DKK -4,412,692.
About MINERVAX ApS
MINERVAX ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Per Bo Pedersen Fischer. The board consists of Veronica Gambillara Fonck (chair), Bita Sehat, Christopher J. Gagliardi and Emmanuelle Coutanceau. The company's owners include Novo Holdings A/S, SUNSTONE LIFE SCIENCE VENTURES FUND III K/S and Wellington Partners Life Sciences V GmbH & Co. KG. The company has 2 employees (2018). In 2025, the company reported a net result of EUR -31,530,000 compared with EUR -29,126,000 the year before. Equity in the 2025 report amounted to EUR 9,787,000.